Cyclerion Therapeutics, Inc.
CYCN
$2.76
$0.2158.45%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.95M | -2.94M | -3.06M | -5.28M | 3.01M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 125.00K | 195.00K | 262.00K | 243.00K | -11.82M |
| Change in Net Operating Assets | -1.01M | -681.00K | -1.54M | -1.20M | -2.64M |
| Cash from Operations | -2.83M | -3.43M | -4.33M | -6.23M | -11.45M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | 0.00 | 10.40M |
| Cash from Investing | -- | -- | -- | 0.00 | 10.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1.38M | 1.38M | -- | 1.95M | 1.95M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -130.00K | -- | -- | -- | 0.00 |
| Cash from Financing | 1.25M | 1.38M | -- | 0.00 | 0.00 |
| Foreign Exchange rate Adjustments | 0.00 | -2.00K | -6.00K | -2.00K | -2.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.58M | -2.06M | -4.34M | -6.24M | -1.05M |